Raymond James & Associates’s Sharps Compliance Corp SMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-118,374
Closed -$698K 4288
2022
Q1
$698K Buy
118,374
+307
+0.3% +$1.93K ﹤0.01% 2850
2021
Q4
$842K Buy
+118,067
New +$906K ﹤0.01% 2730

Other funds holding SMED

Raymond James & Associates's SMED Position: Q2 2022 in Review

Raymond James & Associates sold out of Sharps Compliance Corp (SMED) in Q2 2022, closing a stake of 118,374 shares — an estimated $698K sold.

Raymond James & Associates first reported a position in SMED in Q4 2021 and held it in 2 quarters. The position peaked at $842K in Q4 2021. 67 funds tracked by Wall St. Rank hold SMED as of Q2 2022.

  • Raymond James & Associates reported no remaining Sharps Compliance Corp position as of Q2 2022 after selling out during the quarter.
  • Raymond James & Associates sold 118,374 Sharps Compliance Corp shares in Q2 2022, an estimated $698K.
  • Raymond James & Associates first reported a position in Sharps Compliance Corp in Q4 2021 and held it in 2 quarters.
  • Raymond James & Associates's Sharps Compliance Corp position peaked at $842K in Q4 2021.
  • 67 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q2 2022.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.